Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The macrophage scavenger receptor type A (SR-A) is a trimeric membrane glycoprotein that functions as a pattern recognition receptor in innate immunity and plays a crucial role in lipid metabolism, particularly in the development of atherosclerosis. It is predominantly expressed on tissue macrophages and mediates the uptake of modified lipoproteins, pathogens, and apoptotic cells. Emerging research suggests a role in cancer biology and immunology, making it a potential therapeutic target.
Modulation of SR-A activity is being explored as a therapeutic strategy, but specific drugs directly targeting it are still under development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage Scavenger Receptor Type A (SR-A).